Prica & Partners provides advice and assistance on a variety of pharmaceutical law matters. Our multidisciplinary team of lawyers has extensive experience in all transactions relating to this highly specialized sector having acted as counsel to a number of international pharmaceutical giants.
We understand the environment in which our clients operate and the unique challenges involved in technology transfer.
Prica & Partners' pharmaceutical team is structured to deal with corporate, competition and regulatory, IP, and dispute resolution issues. Our lawyers regularly advise clients on a wide range of subjects including the exploitation of products, product licensing, acquisition and enforcement of patents, and compliance with Serbian and EU regulatory requirements.
In acting for acquiring and divesting companies, investors, licensors and licensees in the pharmaceutical sector we have been involved in carrying out legal due diligence, participating in negotiations, drafting licensing agreements and share transfer documentation.
In addition to product licensing and market authorization issues we also act as counsel to manufacturers in their marketing policy, and in particular with regards to marketing restrictions and distribution channels.
Our expertise includes:
Some of our representative clients are: Boehringer Ingelheim, AstraZeneca, Richter Gedeon Nyrt., Pfizer Inc., Abbott Laboratories S.A., Novartis Pharma Services Inc., Merck & Co. Inc., Sandoz.